PMID,Title,Journal,Year
40925517,Infliximab and ustekinumab clearance better predict endoscopic outcomes than trough concentrations in Crohn's disease.,Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,2025
40920365,Blood proteomic signatures associated with disease activity in Inflammatory Bowel Diseases.,Journal of Crohn's & colitis,2025
40916681,"Research Communication: Combination Therapy of Upadacitinib With Infliximab, Risankizumab, Ustekinumab or Vedolizumab for Refractory Crohn's Disease: A Descriptive Case Series.",Alimentary pharmacology & therapeutics,2025
40908737,Efficacy and safety of biosimilars in gastroenterology: a focus on inflammatory bowel disease management.,Expert opinion on biological therapy,2025
40900639,Combination therapy with biologics and/or small molecules in inflammatory bowel disease: a comprehensive review.,Journal of Crohn's & colitis,2025
40880673,Recurrent Pneumothorax in a Pediatric Patient with Crohn's Disease Receiving Ustekinumab Treatment: Case Report.,Case reports in gastroenterology,2025
40869536,"Update on the Prevalence, Incidence, Mortality, and Trends in Treatment of Inflammatory Bowel Disease in a Population-Based Registry in Catalonia Between 2017 and 2023.",Journal of clinical medicine,2025
40880674,Vancomycin for the Induction and Maintenance of Remission in Biologics Refractory Patient with Ulcerative Colitis and Primary Sclerosing Cholangitis Post-Liver and Bone Marrow Transplantation.,Case reports in gastroenterology,2025
40873576,Case Report: Facial Malassezia folliculitis following infliximab treatment in Crohn's disease.,Frontiers in immunology,2025
40845197,Systematic Review With Meta-Analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Diseases.,Inflammatory bowel diseases,2025
40836379,Real-world efficacy of ustekinumab and vedolizumab in pediatric and young adult patients with inflammatory bowel disease.,Journal of pediatric gastroenterology and nutrition,2025
40835043,Real-world comparison of the effectiveness of tofacitinib and ustekinumab in patients with ulcerative colitis: the TORUS study.,Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,2025
40834298,Resolving Loss of Response to Ustekinumab in Crohn's Disease: POWER Through or Switch Treatment?,Inflammatory bowel diseases,2025
40828456,Realâ€‘world safety and efficacy of biological agents in inflammatory bowel disease: a one-year post-marketing pharmacovigilance observational study in the Calabria region.,Pharmacological reports : PR,2025
40826702,Bacterial dysentery complicated with Crohn's disease: A case report.,Medicine,2025
40806196,"Interplay of Gut Microbiota, Biologic Agents, and Postoperative Anastomotic Leakage in Inflammatory Bowel Disease: A Narrative Review.",International journal of molecular sciences,2025
40790167,A complex case of acute abdomen.,International journal of emergency medicine,2025
40778752,Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA.,Alimentary pharmacology & therapeutics,2025
40736698,Patients Included in Clinical Trials of Biological Drugs for Inflammatory Bowel Disease Do Not Represent the Real-World Population.,The American journal of gastroenterology,2025
40734661,Monthly intravenous maintenance treatment with ustekinumab regains clinical response in patients with Crohn's disease who no longer respond to the drug when administered subcutaneously.,Therapeutic advances in gastroenterology,2025
